These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2073413)

  • 1. Changes in lung macrophages during disease.
    Poulter LW
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):327-31. PubMed ID: 2073413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The macrophage in sarcoid granuloma formation.
    Spiteri MA; Poulter LW; Geraint-James D
    Sarcoidosis; 1989 Oct; 6 Suppl 1():12-4. PubMed ID: 2623371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immune inducer and suppressor macrophages from the normal human lung.
    Spiteri MA; Poulter LW
    Clin Exp Immunol; 1991 Jan; 83(1):157-62. PubMed ID: 1824832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage.
    Spiteri MA; Clarke SW; Poulter LW
    Eur Respir J; 1992 Jun; 5(6):717-26. PubMed ID: 1628729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.
    Spiteri MA; Clarke SW; Poulter LW
    Clin Exp Immunol; 1988 Dec; 74(3):359-64. PubMed ID: 2466589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.
    Ainslie GM; Poulter LW; du Bois RM
    Thorax; 1989 Jun; 44(6):501-9. PubMed ID: 2669224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.
    Campbell DA; Poulter LW; Du Bois RM
    Thorax; 1986 Jun; 41(6):429-34. PubMed ID: 3787519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7.
    Taams LS; Poulter LW; Rustin MH; Akbar AN
    Pathobiology; 1999; 67(5-6):249-52. PubMed ID: 10725795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis.
    Spiteri MA; Clarke SW; Poulter LW
    Eur Respir J; 1992 Apr; 5(4):394-403. PubMed ID: 1532939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of arachidonic acid in human alveolar macrophages from patients with sarcoidosis.
    De Rose V; Crivellari MT; Viganò T; Folco GC; Trentin L; Masciarelli M; Semenzato G; Pozzi E; Gialdroni Grassi G
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():445-8. PubMed ID: 1847782
    [No Abstract]   [Full Text] [Related]  

  • 11. The alveolar macrophage in sarcoidosis.
    du Bois RM
    Sarcoidosis; 1990 Mar; 7(1):15-8. PubMed ID: 2189174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage related morphometry of sarcoid granulomas and inflammatory cell types in broncho-alveolar lavage.
    Kayser K; Hagemeyer O
    Anal Cell Pathol; 1991 Nov; 3(6):335-42. PubMed ID: 1751400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electron microscopy studies of alveolar macrophages in some lung diseases].
    Szüle P; Appel J
    Z Erkr Atmungsorgane; 1987; 169(3):260-8. PubMed ID: 3445647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis of agarose beads by receptors for C3b (CR1) and iC3b (CR3) on alveolar macrophages from patients with sarcoidosis.
    Pettersen HB; Johnson E; Osen SS
    Scand J Immunol; 1990 Dec; 32(6):669-77. PubMed ID: 2148644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies.
    Poulter LW; Campbell DA; Munro C; Janossy G
    Scand J Immunol; 1986 Sep; 24(3):351-7. PubMed ID: 3529367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four monoclonal antibodies, AMH-1, -2, -3, and -4, give varied reactivities with monocytes, alveolar macrophages, and epithelioid-cell granulomas.
    Akiyama J; Chida K; Sato A; Yamashita A
    J Clin Immunol; 1988 Sep; 8(5):372-80. PubMed ID: 3182965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid can alter antigen expression on alveolar macrophages.
    Marianayagam L; Poulter LW
    Clin Exp Immunol; 1991 Sep; 85(3):531-5. PubMed ID: 1893636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis.
    Orosi P; Nugent K
    Lung; 1993; 171(4):225-33. PubMed ID: 8341089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation of alveolar macrophages in pulmonary sarcoidosis correlates with markers of lymphocyte activity in bronchoalveolar lavage fluid].
    Barth J; Kreipe H; Kiemle-Kallee J; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():224-5. PubMed ID: 1973297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.